HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldw...
Cut the Earnings Season Noise: From AI Washing to Real Cash in 10 Outlier Stocks
Heartflow to report Q2 2026 results after market close, host conference call
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026
Heartflow Chief Medical Officer Campbell Rogers disposes of 9,219 common shares worth $237,077.68
Heartflow CEO John C.M. Farquhar disposes of 22,562 shares worth $626,095.5
HeartFlow Sees Insider Stock Selling